Grant: Master's Award: Canada Graduate Scholarships
York University (Toronto, Ontario)
$17,500.00
Regulation of Skeletal Muscle Glucose and Fat Metabolism by Omega-3 Fatty Acids
FY 2017-18
Summary
Omega-3 fatty acids are well known for their beneficial health effects, with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) being the ones with the greatest therapeutic potential. In this context, omega-3 fatty acids have been shown to improve glucose tolerance in humans. These effects could derive from a direct regulatory effect of these fatty acids on glucose utilization in skeletal muscle. However, only limited information is available regarding the potential beneficial effects of EPA and DHA on skeletal muscle glucose and fat metabolism. Importantly, skeletal muscles account for ~40% of body weight in men and ~30% in women and have great capacity to clear a large amount of blood glucose. In fact, skeletal muscle is the main site for insulin-stimulated glucose disposal. Thus, a potential direct effect of omega-3 fatty acids could be of therapeutic value for type 2 diabetes, a disease which is characterized by elevated blood glucose levels. Thus, the focus of my research will be to investigate the direct effects of EPA and DHA on glucose and fat metabolism in skeletal muscle cells, as well as the molecular mechanisms underlying these effects. Due to the anti-inflammatory properties of EPA and DHA, I will also study whether these fatty acids regulate glucose and fat metabolism by reducing the negative impact of inflammation on insulin signaling in skeletal muscles. These studies will advance our knowledge regarding the role of omega-3 fatty acids in health and disease, which can be of great therapeutic value for the treatment and prevention of disorders such as obesity and type 2 diabetes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
392073
Name
Katsnelson Glen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Regulation of Skeletal Muscle Glucose and Fat Metabolism by Omega-3 Fatty Acids
Programtype2
Studentship Programs
Orgnameinp2
York University (Toronto, Ontario)
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Energy Metabolism; Nutrition; Omega 3; Skeletal Muscle; Type 2 Diabetes
Abstract
Omega-3 fatty acids are well known for their beneficial health effects, with docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) being the ones with the greatest therapeutic potential. In this context, omega-3 fatty acids have been shown to improve glucose tolerance in humans. These effects could derive from a direct regulatory effect of these fatty acids on glucose utilization in skeletal muscle. However, only limited information is available regarding the potential beneficial effects of EPA and DHA on skeletal muscle glucose and fat metabolism. Importantly, skeletal muscles account for ~40% of body weight in men and ~30% in women and have great capacity to clear a large amount of blood glucose. In fact, skeletal muscle is the main site for insulin-stimulated glucose disposal. Thus, a potential direct effect of omega-3 fatty acids could be of therapeutic value for type 2 diabetes, a disease which is characterized by elevated blood glucose levels. Thus, the focus of my research will be to investigate the direct effects of EPA and DHA on glucose and fat metabolism in skeletal muscle cells, as well as the molecular mechanisms underlying these effects. Due to the anti-inflammatory properties of EPA and DHA, I will also study whether these fatty acids regulate glucose and fat metabolism by reducing the negative impact of inflammation on insulin signaling in skeletal muscles. These studies will advance our knowledge regarding the role of omega-3 fatty acids in health and disease, which can be of great therapeutic value for the treatment and prevention of disorders such as obesity and type 2 diabetes.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Katsnelson, Glen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~